The UK's future vaccine manufacturing site which is in Oxfordshire has been sold.
The buyer of the Vaccine Manufacturing and Innovation Centre (VMIC) is US pharmaceutical firm Catalent Biotherapeutics.
In a statement published today, Catalent said it had acquired the site in Oxfordshire but did not state how much it had paid.
READ MORE: Outcry as publicly funded £200 million Vaccine centre sold to a US business
The VMIC, which is being built at Harwell Campus with the intention of helping to prepare the country for future pandemics, was reportedly put up for sale at the end of last year despite receiving more than £200 million in public investment.
The investment includes £90 million of cash the UK Government ploughed into the project to accelerate its construction during the coronavirus pandemic.
Oxford City Council protested this sale, and voted unanimously against the sale on March 22.
Follow us on Facebook, Twitter, Instagram and Tik Tok
Got a story for us? Send us your news and pictures here
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules hereLast Updated:
Report this comment Cancel